Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
How has the future investment program stimulated research and innovation in health?
Bordet R, Dantonel JC, Vacaresse E, Le Jeunne C, Benhabiles N, Beretz A, Boitard C, Debette S, Duluc G, Froguel P, Garbil B, Lyonnet S, Mahfoudi A, Marquet P, Mouthon F, Rascol O, Richard V, Simon E, Varoqueaux N, Watier H, Zins M. Bordet R, et al. Among authors: mouthon f. Therapie. 2022 Jan-Feb;77(1):19-24. doi: 10.1016/j.therap.2022.01.009. Epub 2022 Jan 18. Therapie. 2022. PMID: 35148896
Comment le programme d’investissements d’avenir a-t-il stimulé la recherche et l’innovation en santé ?
Bordet R, Dantonel JC, Vacaresse E, Le Jeunne C, Benhabiles N, Beretz A, Boitard C, Debette S, Duluc G, Froguel P, Garbil B, Lyonnet S, Mahfoudi A, Marquet P, Mouthon F, Rascol O, Richard V, Simon E, Varoqueaux N, Watier H, Zins M. Bordet R, et al. Among authors: mouthon f. Therapie. 2022 Jan-Feb;77(1):11-17. doi: 10.1016/j.therap.2022.01.005. Epub 2022 Jan 12. Therapie. 2022. PMID: 35101283 French. No abstract available.
Use of real-world evidence in translational pharmacology research.
Charvériat M, Darmoni SJ, Lafon V, Moore N, Bordet R, Veys J, Mouthon F; SFPT Translational Research in Pharmacology group. Charvériat M, et al. Among authors: mouthon f. Fundam Clin Pharmacol. 2022 Apr;36(2):230-236. doi: 10.1111/fcp.12734. Epub 2021 Nov 2. Fundam Clin Pharmacol. 2022. PMID: 34676579 Review.
Innovative approaches in CNS drug discovery.
Charvériat M, Lafon V, Mouthon F, Zimmer L. Charvériat M, et al. Among authors: mouthon f. Therapie. 2021 Mar-Apr;76(2):101-109. doi: 10.1016/j.therap.2020.12.006. Epub 2020 Dec 5. Therapie. 2021. PMID: 33342585 Review.
Connexins as therapeutic targets in neurological and neuropsychiatric disorders.
Charvériat M, Mouthon F, Rein W, Verkhratsky A. Charvériat M, et al. Among authors: mouthon f. Biochim Biophys Acta Mol Basis Dis. 2021 May 1;1867(5):166098. doi: 10.1016/j.bbadis.2021.166098. Epub 2021 Feb 3. Biochim Biophys Acta Mol Basis Dis. 2021. PMID: 33545299 Free article. Review.
Pharmaco-fUS in cognitive impairment: Lessons from a preclinical model.
Vidal B, Pereira M, Valdebenito M, Vidal L, Mouthon F, Zimmer L, Charvériat M, Droguerre M. Vidal B, et al. Among authors: mouthon f. J Psychopharmacol. 2022 Nov;36(11):1273-1279. doi: 10.1177/02698811221128963. Epub 2022 Oct 7. J Psychopharmacol. 2022. PMID: 36205074
38 results